Clinical characteristics of tuberculosis in liver or heart transplant recipients

Tuberculosis and Respiratory Diseases

Volumn 61, Issue 5, 2006, Pages 440-446

  Jung, Hoon ^a   Oh, Yeon Mok ^a   Sang, Do Lee ^a   Woo, Sung Kim ^a   Dong, Soon Kim ^a   Won, Dong Kim ^a   Kim, Jae Joong ^a   Sung, Gyu Lee ^a   Tae, Sun Shim ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Heart transplantation; Liver transplantation; Tuberculosis

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; HEPATITIS B SURFACE ANTIGEN; HEPATITIS E ANTIGEN; ISONIAZID; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; DEATH; DIABETES MELLITUS; EXTRAPULMONARY TUBERCULOSIS; FEMALE; GRAFT REJECTION; HEART GRAFT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LEUKOPENIA; LIVER GRAFT; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; TREATMENT DURATION;

EID: 33847386413     PISSN: 17383536     EISSN: None     Source Type: Journal    
DOI: 10.4046/trd.2006.61.5.440     Document Type: Article

References (25)

1. Meyers BR, Halpern M, Sheiner P, Mendelson MH, Neibart E, Miller C. Tuberculosis in liver transplant patients. Transplantation 1994;58:301-6.
2. Atasever A, Bacakoglu F, Toz H, Basoglu OK, Duman S, Basak K, et al. Tuberculosis in renal transplant recipients on various immunosuppressive regimens. Nephrol Dial Transplant 2005;20:797-802.
3. Park YS, Choi JY, Cho CH, Chang KH, Song YG, Kim YS, et al. Clinical outcomes of tuberculosis in renal transplant recipients. Yonsei Med J 2004;45:865-72.
4. Morales P, Briones A, Torres JJ, Sole A, Perez D, Pastor A. Pulmonary tuberculosis in lung and heart-lung transplantation: fifteen years of experience in a single center in Spain. Transplant Proc 2005;37:4050-5.
5. Aguado JM, Herrero JA, Gavalda J, Torre-Cisneros J, Blanes M, Rufi G, et al. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA Transplantation 1997;63:1278-86.
6. Korea Center for Disease Control and Prevention & Korea Institute of Tuberculosis. Annual report on the notified tuberculosis patients in Korea (based on Korean tuberculosis surveillance system: 2004.1. 2004.12. Korea: 2005.
7. Ahn SJ, Han SK, Im EH, Woo JY, Yoon YS, Bang BK, et al. The clinical characterisitcs of tuberculosis in renal transplant recipients. J Korean Soc Transplant 1991;5:69-74.
8. Park SB, Suk J, Joo I, Kim HC, Cho WH, Park CH. Tuberculosis complicating kidney transplantation. J Korean Soc Transplant 1995;9:95-102.
9. Kim MS, Byun CG, Lee KY, Kim SI, Kim SK, Chang J, et al. Mycobacterial infections after renal transplantation. J Korean Soc Transplant 1995;9:103-9.
10. Im EH, Han SK, Jung IG, Ahn SJ, Yoon YS, Bang BK, et al. A case of tuberculosis occurred on the graft kidney. J Korean Soc Transplant 1991;5:129-34.
11. Ki HK, Son JS, Oh WS, Peck KR, Lee NY, Kim SJ, et al. Infectious complication after liver transplantation according to donor: comparison between orthotopic and living donor transplantation. Infect Chemother 2004;36:139-48.
12. Meyers BR, Papanicolaou GA, Sheiner P, Emre S, Miller C. Tuberculosis in orthotopic liver transplant patients: increased toxicity of recommended agents: cure of disseminated infection with nonconventional regimens. Transplantation 2000;69:64-9.
13. John GT, Shankar V. Mycobacterial infections in organ transplant recipients. Semin Respir Infect 2002;17:274-83.
14. Benito N, Sued O, Moreno A, Horcajada JP, Gonzalez J, Navasa M, et al. Diagnosis and treatment of latent tuberculosisinfection in liver transplant recipients in an endemic area. Transplantation 2002;74:1381-6.
15. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep 2000;49:1-51.
16. Singh N, Paterson DL. Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Dis 1998;27:1266-77.
17. Agarwal SK, Gupta S, Dash SC, Bhowmik D, Tiwari SC. Prospective randomised trial of isoniazid prophylaxis in renal transplant recipient. Int Urol Nephrol 2004;36:425-31.
18. Keane J. TNF-blocking agents and tuberculosis: new drugs illuminate an old topic. Rheumatology 2005;44:714-20.
19. Wallis RS, Broder M, Wong J, Lee A, Hoq L. Reactivation of latent granulomatous infections by infliximab. Clin Infect Dis 2005;41(Suppl 3):S194-8.
20. Rieder HL, Snider DE Jr, Cauthen GM. Extra-pulmonary tuberculosis in the United States. Am Rev Respir Dis 1990;141:347-51.
21. John GT, Shankar V, Abraham AM, Mukundan U, Thomas PP, Jacob CK. Risk factors for post-transplant tuberculosis. Kidney Int 2001;60:1148-53.
22. Vachharajani TJ, Oza UG, Phadke AG, Kirpalani AL. Tuberculosis in renal transplant recipients: rifampicin sparing treatment protocol. Int Urol Nephrol 2002;34:551-3.
23. Chou NK, Liu LT, Ko WJ, Hsu RB, Chen YS, Yu HY, et al. Various clinical presentations of tuberculosis in heart transplant recipients. Transplant Proc 2004;36:2396-8.
24. Bravo C, Roldan J, Roman A, Degracia J, Majo J, Guerra J, et al. Tuberculosis in lung transplant recipients. Transplantation 2005;79:59-64.
25. Munoz P, Rodriguez C, Bouza E. Mycobacterium tuberculosis infection in recipients of solid organ transplants. Clin Infect Dis 2005;40:581-7.